101 related articles for article (PubMed ID: 2504810)
1. Applications of therapy in animal models to bacterial infection in human disease.
Tunkel AR; Scheld WM
Infect Dis Clin North Am; 1989 Sep; 3(3):441-59. PubMed ID: 2504810
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Sande MA; Brooks-Fournier RA; Gerberding JL
Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of the experimental model of bacterial endocarditis].
Carbon C
Bull Acad Natl Med; 1995 Apr; 179(4):767-74; discussion 775-6. PubMed ID: 7648311
[TBL] [Abstract][Full Text] [Related]
6. Immunocompromised animal models for the study of antibiotic combinations.
Calandra T; Glauser MP
Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of in vitro antibiotic sensitivity: critical features of the MIC].
Malcangi A; Mineccia C; Martinetto P
G Batteriol Virol Immunol; 1989; 82(1-12):165-73. PubMed ID: 2518761
[TBL] [Abstract][Full Text] [Related]
8. Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis.
Gerberding JL; Sande MA
Rev Infect Dis; 1986; 8 Suppl 3():S315-8. PubMed ID: 3529324
[TBL] [Abstract][Full Text] [Related]
9. Experimental staphylococcal endocarditis: an overview.
Gutschik E
Scand J Infect Dis Suppl; 1983; 41():87-94. PubMed ID: 6589765
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antimicrobial agents in the rabbit model of endocarditis.
Sande MA
Rev Infect Dis; 1981; 3 suppl():S240-9. PubMed ID: 7342288
[TBL] [Abstract][Full Text] [Related]
11. A critique of animal models in antibiotic research.
Barza M
Scand J Infect Dis Suppl; 1978; (14):109-17. PubMed ID: 279963
[TBL] [Abstract][Full Text] [Related]
12. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
Dhawan VK; Yeaman MR; Bayer AS
J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
Fernández Guerrero ML; de Górgolas M
J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993-2003).
Tolar EL; Hendrix DV; Rohrbach BW; Plummer CE; Brooks DE; Gelatt KN
J Am Vet Med Assoc; 2006 Jan; 228(1):80-5. PubMed ID: 16426172
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
18. Bacteriostatic versus bactericidal activity.
Mulligan MJ; Cobbs CG
Infect Dis Clin North Am; 1989 Sep; 3(3):389-98. PubMed ID: 2671128
[TBL] [Abstract][Full Text] [Related]
19. A review of models for the therapy of experimental infections.
Bergeron MG
Scand J Infect Dis Suppl; 1978; (14):189-206. PubMed ID: 279972
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
